期刊文献+

甘露糖调控GLUT1/SLIT2通路抑制三阴性乳腺癌增殖的影响及机制研究 被引量:1

Effect of mannose regulating GLUT1/SLIT2 pathway on progressionof triple-negative breast cancer
下载PDF
导出
摘要 乳腺癌是最常见的女性恶性肿瘤之一。目前认为,肿瘤细胞主要通过糖酵解途径摄取葡萄糖。甘露糖对肿瘤的影响备受关注,其抗肿瘤机制与癌细胞糖代谢密切相关。文章通过体外体内实验,观察甘露糖对乳腺癌增殖以及GLUT1,SLIT2,ROBO1蛋白表达的影响,旨在寻求调控乳腺癌增殖的新靶点,为临床诊断治疗乳腺癌提供理论依据。研究结果表明,甘露糖可抑制三阴性乳腺癌细胞的增殖及迁移能力,其机制可能与甘露糖调控GLUT1/SLIT2/ROBO1信号轴相关。 Breast cancer is one of the most common female malignant tumors.At present,it is believed that tumor cells mainly take glucose through glycolysis.Recent years,more and more research has been focused on the effect of mannose on tumor.The antitumor mechanism of mannose is closely related to glycolysis.This study is to explore the effect of mannose on the proliferation of triple negative breast cancer cells and its molecular mechanism.The effect of mannose on the proliferation and the expression of GLUT1,SLIT2,ROBO1 proteins of breast cancer cells was observed in vitro and in vivo.The purpose is to seek new targets to regulate the proliferation of triple-negative breast cancer cells and provide the basis of theory for the treatment of breast cancer.Mannose inhibits the progression and migration of triple-negative breast cancer.The mechanism may be related to the regulation of GLUT1/SLIT2/ROBO1 pathway by mannose.
作者 张晓金 卞勇华 王楠 李梦琳 Zhang Xiaojin;Bian Yonghua;Wang Nan;Li Menglin(Jiangsu Vocational College of Medicine,Yancheng 224005,China)
出处 《江苏科技信息》 2023年第12期75-80,共6页 Jiangsu Science and Technology Information
基金 2020年江苏省盐城市医学发展项目 项目编号:YK2020064。
关键词 甘露糖 三阴性乳腺癌 增殖 糖代谢 mannose triple-breast cancer progression glycometabolism
  • 相关文献

参考文献2

二级参考文献22

  • 1Kang SS, Chun YK, Hur MH, et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. JPN J Cancer Res,2002;93(10):1123-1128.
  • 2Stackhouse BL, Williams H, Berry P, etal. Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer. Breast Cancer Res Tr,2005 ;93(3):247-253.
  • 3Zamora-Leon SP, Golde DW, Concha II, et al. Expression of the fructose transporter GLUTS in human breast cancer. Proc Natl Acad Sci USA,1996,93(5) :1847-1852.
  • 4Gatenby RA, Gillies RJ. Why do cancers have high aerobic glyeolysis? Nat Rev Cancer,2004,4(11) :891-899.
  • 5Stubbs M, Bashford CL, Griffiths JR. Understanding the tumor metabolic phenotype in the genom~c era. Curr Mol Med, 2003;3(1) :49-59.
  • 6Maria L, Mached A, Suzanne R, etal. Molecular and cellular regulation of glucose tranporter(GLUT) protein in cnacer. J Cell Physiol,2005,202(3) :654-662.
  • 7Rivenzon-Segal D, Boldin-Adamsky S, SegerD, et al. Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int J Cancer, 2003, 107(2):177-182.
  • 8Bos R, van Der Hoeven JJ, van Der Wall E, et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol, 2002, 20 (2) : 379-387.
  • 9Ito S, Fukusato T, Nemoto T, et al. Coexpression of glucose tranporter 1 and matrix metalloproteinase-2 in human cancers. J Natl Caneer Inst,2002,94(14):1080-1091.
  • 10Hoskin PJ, Sibtain A, Daley FM, etal. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer:relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer,2003;89(7) :1290-1297.

共引文献4

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部